Stock Events

Stock Events

Grace Therapeutics (GRCE) Q2 2026 Earnings

18JunConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.28

-0.21

-0.13

-0.06

Details

Expected EPS

-0.23

Actual EPS

-0.06

Surprise EPS

0.17

Surprise Percent

+73.91%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.06 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.